GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cue Biopharma Inc (FRA:1UC) » Definitions » Change In Prepaid Assets

Cue Biopharma (FRA:1UC) Change In Prepaid Assets : €0.18 Mil (TTM As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Cue Biopharma Change In Prepaid Assets?

Cue Biopharma's Change In Prepaid Assets for the quarter that ended in Mar. 2025 was €-0.98 Mil. It means Cue Biopharma's Prepaid Assets declined by €0.98 Mil from Dec. 2024 to Mar. 2025 .

Cue Biopharma's Change In Prepaid Assets for the fiscal year that ended in Dec. 2024 was €0.23 Mil. It means Cue Biopharma's Prepaid Assets increased by €0.23 Mil from Dec. 2023 to Dec. 2024 .


Cue Biopharma Change In Prepaid Assets Historical Data

The historical data trend for Cue Biopharma's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cue Biopharma Change In Prepaid Assets Chart

Cue Biopharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Prepaid Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.31 -0.18 -0.34 0.02 0.23

Cue Biopharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Prepaid Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.92 0.20 0.31 0.65 -0.98

Cue Biopharma Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cue Biopharma Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of Cue Biopharma's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Cue Biopharma Business Description

Traded in Other Exchanges
Address
40 Guest Street, Boston, MA, USA, 02135
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Cue Biopharma Headlines

No Headlines